Metabolic Syndrome
Consuming high-fat dairy tied to less metabolic syndrome, diabetes, hypertension
Psychiatric patients with altered metabolic profile may not receive adequate treatment
Early monitoring of metabolic traits among patients on antipsychotics may reduce adverse effects
Should the term ‘metabolic syndrome’ be changed to ‘circadian syndrome’?
The underlying etiology of the metabolic syndrome, a cardiometabolic risk factor cluster — central obesity, low HDL cholesterol, impaired glucose tolerance, elevated triglycerides and hypertension — remains the subject of debate. Gerald Reaven, MD, the Stanford University researcher who coined the syndrome’s original name of “syndrome X,” suggested insulin resistance was the cause, but this is only partly correct. Insulin resistance is just one of the outcomes of circadian dysfunction, along with the above risk factors.
‘Metabolic syndrome’ label imprecise, but cardiometabolic risk is real
The term “metabolic syndrome” has been used since the mid-1990s to describe a constellation of risk factors that predispose adults to develop diabetes, cardiovascular disease or both. These factors, many of which are linked to obesity, inactivity and unhealthy diet, appear to be emerging among younger patients. From 1988-1994 to 2007-2012, the prevalence of metabolic syndrome among U.S. adults rose by more than 35%, from 25.3% to 34.2%, according to the CDC.
Association between arterial stiffness, depression mediated by metabolic syndrome, inflammation
Future cardiovascular risk among adult patients with depression may be identifiable early using combined data on metabolic syndrome and inflammation, according to results of a population-based cohort study published in JAMA Psychiatry. Researchers used this data to determine that one-third of the association of depression with elevated arterial stiffness index levels during midlife may be accounted for by combined inflammatory and metabolic syndrome processes.